A specially designed drug called SRT-1720 has been shown to extend life an average of 44% for obese mice by decreasing fat in the liver and increasing sensitivity to insulin, according to research from the National Institute on Aging. Similar drugs are being tested in human clinical trials, with an eye on creating drugs to help people of all sizes live longer.

Related Summaries